2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline) a report of the American …

TW Rooke, AT Hirsch, S Misra, AN Sidawy… - Circulation, 2011 - Am Heart Assoc
The results of late-breaking clinical trials presented at the annual scientific meetings of the
ACC, AHA, European Society of Cardiology, Society for Vascular Surgery, Society of …

European Diabetes Working Party for Older People 2011 clinical guidelines for type 2 diabetes mellitus. Executive summary

AJ Sinclair, G Paolisso, M Castro… - Diabetes & …, 2011 - Elsevier
AIM: The Clinical Guidelines provide an opportunity to summarise the interpretation of
relevant clinical trial evidence for older people with diabetes. They are intended to support …

Heart disease and stroke statistics—2011 update: a report from the American Heart Association

VL Roger, AS Go, DM Lloyd-Jones, RJ Adams… - Circulation, 2011 - Am Heart Assoc
Summary Each year, the American Heart Association (AHA), in conjunction with the Centers
for Disease Control and Prevention, the National Institutes of Health, and other government …

ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral …

… by: the European Stroke Organisation (ESO … - European heart …, 2011 - academic.oup.com
Cardiovascular diseases (CVDs) are the leading cause of death and disability in Europe,
posing a great social and economic burden. Coronary artery disease (CAD) is the cause of …

Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results

MD Dake, GM Ansel, MR Jaff, T Ohki… - Circulation …, 2011 - Am Heart Assoc
Background—Sustained benefits of drug-eluting stents in femoropopliteal arteries have not
been demonstrated. This prospective, multinational, randomized study was designed to …

Secondary prevention and mortality in peripheral artery disease: National Health and Nutrition Examination Study, 1999 to 2004

RL Pande, TS Perlstein, JA Beckman, MA Creager - Circulation, 2011 - Am Heart Assoc
Background—Whether individuals with peripheral artery disease (PAD) identified by
screening ankle-brachial index benefit from preventive therapies to reduce cardiovascular …

[HTML][HTML] Use and utility of ankle brachial index in patients with diabetes

L Potier, C Abi Khalil, K Mohammedi… - European Journal of …, 2011 - Elsevier
Ankle brachial index (ABI) is a simple method to screen peripheral arterial disease (PAD)
and to evaluate cardiovascular (CV) prognosis in the general population. Measuring it …

Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia

J Belch, WR Hiatt, I Baumgartner, IV Driver, S Nikol… - The Lancet, 2011 - thelancet.com
Background Patients with critical limb ischaemia have a high rate of amputation and
mortality. We tested the hypothesis that non-viral 1 fibroblast growth factor (NV1FGF) would …

Exercise rehabilitation in peripheral artery disease: functional impact and mechanisms of benefits

NM Hamburg, GJ Balady - Circulation, 2011 - Am Heart Assoc
In the United States, 8 million adults have peripheral artery disease (PAD), a number that is
likely to escalate as the population ages. 1–3 Lower-extremity PAD is a component of …

Vascular complications in patients undergoing femoral cannulation for extracorporeal membrane oxygenation support

T Bisdas, G Beutel, G Warnecke, MM Hoeper… - The Annals of thoracic …, 2011 - Elsevier
BACKGROUND: Extracorporeal membrane oxygenation (ECMO) is a well-established
treatment for severe cardiopulmonary failure. Patients undergoing ECMO support through …